Biopharma Contract Manufacturing Prices Go Up—and Down

Published on: 
BioPharm International, BioPharm International-09-15-2014, Volume 2014 eBook, Issue 3

A dynamic market, industry consolidation, and demand fluctuations lead to a mixed picture of pricing results.

 

A dynamic market, industry consolidation, and demand fluctuations lead to a mixed picture of pricing results.

Advertisement

 

from BioPharm International’s 2014 Outsourcing Strategies eBook.

 

View other articles in the 

.

 

 

 

 

 

Related Content:

OutsourcingBioBusinessManufacturingManufacturing, BiologicsContract Manufacturing, Biopharmaceutical ProductionBioPharm International-09-15-2014
Sartorius and SPARTA Biodiscovery Partner on Novel Nanoparticle Analysis Platform
BARDA Awards Gritstone bio $433 Million Contract for Phase IIb Study of Next-Gen COVID-19 Vaccine
Hi-Fidelity Fill/Finish for Biologics